Wright State University

Jeffrey B. Travers

Professor and chair of pharmacology, 18 Sept 2025, reporter.nih.gov

NCT05734235

Phase 1, Completed, 2018, 8 people, 17 Feb 2023, clinicaltrials.gov

NCT05287724

Early phase 1, Completed, 2022, 20 people, 18 Mar 2022, clinicaltrials.gov

NCT04036188

Early phase 1, Recruiting, 2019, 24 people, 29 Jul 2019, clinicaltrials.gov

NCT03932162

Early phase 1, Recruiting, 2019, 24 people, 30 Apr 2019, clinicaltrials.gov

NCT03643744

Phase 1, Terminated, 2019, 12 people, 23 Aug 2018, clinicaltrials.gov

National Institute on Aging

RF1, Wounding Therapy and Photocarcinogenesis, RF1AG048946, US$877.3k, 2014–2027, 18 Sept 2025, reporter.nih.gov

National Institute on Aging

R01, Wounding Therapy and Photocarcinogenesis, R01AG048946, US$449.4k, 2014–2025, 20 Aug 2024, reporter.nih.gov